Back to Results

Raia Drogasil SA ADR (RADLY)

Raia Drogasil S.A. ADR is a depositary receipt listed on OTC Markets and tied to Raia Drogasil S.A.’s common shares. The underlying company operates in Brazil’s consumer staples retail space, focusing on the sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its distribution channels include physical stores, telesales, and call centers. Raia Drogasil was founded in 1905 and is headquartered in São Paulo, Brazil.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-RADL.Y
$4.99
36.7% Upside
Undervalued
$5.40
47.9% Upside
Undervalued
Good
July 13, 2026
December 11, 2026
0.06
0.9%
August 4, 2026
25.2x
4.5x
0.7x
6.417 B
7.914 B
21.0%
74.9%
6.2
50.6%
98.7%
Valuation • Fair Value

Raia Drogasil SA ADR (OTC-RADL.Y) Fair Value by Valuation Model

Compare the primary fair value estimate for Raia Drogasil SA ADR (OTC-RADL.Y) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$4.99

Estimated upside of 36.7% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$5.47

Discounted cash flow valuation reference.

Ben Graham Formula Value

$1.62

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$5.07

Earnings power value estimate.

Comps Fair Value

$4.50

Comparable-company valuation reference.

Analyst Price Target

$5.40

Analysts imply upside of 47.9%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Raia Drogasil SA ADR (OTC-RADL.Y) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Raia Drogasil SA ADR (OTC-RADL.Y)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

8.793 B

Current operating scale indicator.

Revenue Forecast

8.945 B

Forward revenue estimate.

EBITDA

679 M

Current operating profitability reference.

EBITDA Forecast

759.7 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Raia Drogasil SA ADR (OTC-RADL.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Raia Drogasil SA ADR (OTC-RADL.Y)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.78

No elevated caution signal from this screen.

Altman Z-Score

6.2

Relatively strong balance-sheet zone.

FCF / Net Income

98.7%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Raia Drogasil SA ADR (OTC-RADL.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Raia Drogasil SA ADR (OTC-RADL.Y)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 4, 2026

Days to Earnings

14

Dividend Payment Date

December 11, 2026

Ex-Dividend Date

July 13, 2026

Dividend Yield

0.9%

Income yield reference.

Upcoming Dividend

0.06

Upcoming distribution amount.

Payment Type

Multiple Dividends

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

50.6%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Raia Drogasil SA ADR (OTC-RADL.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Raia Drogasil SA ADR (OTC-RADL.Y) Stock Forecast & Technical Outlook

Review Raia Drogasil SA ADR (OTC-RADL.Y) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Raia Drogasil SA ADR (OTC-RADL.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Raia Drogasil SA ADR (OTC-RADL.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Raia Drogasil SA ADR (OTC-RADL.Y) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Raia Drogasil SA ADR (OTC-RADL.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Raia Drogasil SA ADR (OTC-RADL.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Raia Drogasil SA ADR (OTC-RADL.Y)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Raia Drogasil SA ADR (OTC-RADL.Y) has a Hold consensus, with 0 buy, 1 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 1
Sell 0
FAQ • Fast Investor Answers

Raia Drogasil SA ADR (OTC-RADL.Y) Stock FAQ

Quick answers about Raia Drogasil SA ADR (OTC-RADL.Y) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$4.99
Estimated upside 36.7%
Valuation Rating
Undervalued
Estimated upside of 36.7%
Analyst Target
$5.40
Implied upside 47.9%
Financial Health
Good
Current financial-health read

The current fair value estimate for Raia Drogasil SA ADR (OTC-RADL.Y) is $4.99. This implies an estimated upside of 36.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 36.7% versus the current market price.

The available analyst price target for Raia Drogasil SA ADR (OTC-RADL.Y) is $5.40. The analyst target implies estimated upside of 47.9%.

The current financial health read for Raia Drogasil SA ADR (OTC-RADL.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Raia Drogasil SA ADR (OTC-RADL.Y) is August 4, 2026.

Based on the current data, dividend yield is 0.9%, upcoming dividend amount is 0.06, ex-dividend date is July 13, 2026, payment date is December 11, 2026.

The current P/E ratio listed for Raia Drogasil SA ADR (OTC-RADL.Y) is 25.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Raia Drogasil SA ADR is 6.417 B.

The current enterprise value listed for Raia Drogasil SA ADR is 7.914 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Raia Drogasil SA ADR is OTC-RADL.Y, and the stock is listed on OTC Markets.

Raia Drogasil SA ADR (OTC-RADL.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Raia Drogasil SA ADR is 21.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Raia Drogasil SA ADR is 74.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Consumer Staples Distribution & Retail Stocks on OTC Markets View more

Alimentation Couche Tard Inc (ANCTF) Alimentation Couche Tard Inc (ANCTF)
Wal Mart de Mexico SAB de CV (WMMVF) Wal Mart de Mexico SAB de CV (WMMVF)
Wal Mart de Mexico SAB de CV ADR (WMMVY) Wal Mart de Mexico SAB de CV ADR (WMMVY)
Tesco PLC (TSCDF) Tesco PLC (TSCDF)
Tesco PLC (TSCDY) Tesco PLC (TSCDY)
Koninklijke Ahold Delhaize NV (AHODF) Koninklijke Ahold Delhaize NV (AHODF)
Koninklijke Ahold Delhaize NV ADR (ADRNY) Koninklijke Ahold Delhaize NV ADR (ADRNY)
Seven & i Holdings Co Ltd ADR (SVNDY) Seven & i Holdings Co Ltd ADR (SVNDY)
Seven & i Holdings Co., Ltd. (SVNDF) Seven & i Holdings Co., Ltd. (SVNDF)
Aeon Co Ltd ADR (AONNY) Aeon Co Ltd ADR (AONNY)
Coles Group Ltd (CLEGF) Coles Group Ltd (CLEGF)
Carrefour SA PK (CRRFY) Carrefour SA PK (CRRFY)
CP All PCL ADR (CPPCY) CP All PCL ADR (CPPCY)
Jeronimo Martins SGPS SA ADR (JRONY) Jeronimo Martins SGPS SA ADR (JRONY)
J Sainsbury PLC OTC (JSAIY) J Sainsbury PLC OTC (JSAIY)
Marks & Spencer Group Plc (MAKSY) Marks & Spencer Group Plc (MAKSY)
Marks and Spencer Group PLC (MAKSF) Marks and Spencer Group PLC (MAKSF)
Shoprite Holdings Ltd ADR (SRGHY) Shoprite Holdings Ltd ADR (SRGHY)
Kesko Oyj ADR (KKOYY) Kesko Oyj ADR (KKOYY)
Dino Polska SA ADR (DNOPY) Dino Polska SA ADR (DNOPY)
Etablissementen Franz Colruyt NV ADR (CUYTY) Etablissementen Franz Colruyt NV ADR (CUYTY)
Axfood AB ADR (AXFOY) Axfood AB ADR (AXFOY)
DFI Retail Group Holdings Ltd DRC (DFIHY) DFI Retail Group Holdings Ltd DRC (DFIHY)
Clicks Group Ltd (CLCGY) Clicks Group Ltd (CLCGY)